A subset of human natural killer cells isolated and characterized by monoclonal antibodies
✍ Scribed by Jürgen Lohmeyer; Peter Rieber; Helmut Feucht; Judith Johnson; Martin Hadam; Gert Riethmüller
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 632 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Monoclonal antibodies were induced against leukemic T cells from a patient with chronic lymphocytic leukemia exhibiting natural killer (NK) activity. Two antibodies, termed T811 and M522, reacted by indirect immunofluorescence with distinct subpopulations of normal human mononuclear blood cells. The antibody T811 defines a surface antigen which is restricted to a subset of the T cell lineage. The antigen recognized by the second antibody, M522, is expressed on monocytes and polymor‐phonuclear leukocytes and, in addition, on 9–17% of nonadherent peripheral blood leukocytes (NAL). It is shown that the total NK activity of NAL is confined to the subset of cells expressing the M522‐defined antigen. Moreover, the portion of NK cytotoxicity associated with T lymphocytes is mediated by a subpopulation which is characterized by the simultaneous expression of the T811‐ and the M522‐defined antigens. This population comprises about 4% of NAL and could be isolated to a purity of > 85%.
📜 SIMILAR VOLUMES
## Abstract Human peripheral blood NK cells may be divided into two main subsets: CD56^bright^CD16^−^ and CD56^dim^CD16^+^. Since TGF‐β is known to influence the development of many leukocyte lineages, its effects on NK cell differentiation either from human CD34^+^Lin^−^ hematopoietic progenitor/s
## Abstract Studies on interactions between natural killer (NK) cells and freshly isolated human tumor cells are still relatively scarce. With respect to the understanding of NK cell interactions with human tumors __in vivo__, and attempts to better predict the outcome of NK cell‐mediated adoptive
The isolation and characterization of human monoclonal antibodies (humAbs) against the hepatitis C Virus (HCV) glycoproteins E1 and E2 are described. B-cells from blood donors with anti-HCV were transformed with Epstein-Barr virus. The supernatants of the resulting lymphoblastoid clones were screene